EUVIMEDEUVIMED entdecken
Crossref

A founder deletion in ECM1 of 1163 bp causes lipoid proteinosis in the southeast region of Turkiye

Elifcan Taşdelen iD, Abdullah Sezer iD, Isa An iD

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Elifcan Taşdelen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Ankara Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Extracellular Matrix Proteins, Founder Effect, Lipoid Proteinosis of Urbach and Wiethe, Pedigree. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipoid proteinosis (LP) is an inherited disorder characterized by the accumulation of hyaline‐like material in the skin, oral cavity, and larynx. The primary symptoms include hoarseness, restricted tongue movements, and various skin lesions. LP is caused by biallelic pathogenic variants in the ECM1 gene. We studied 20 patients from nine different families with LP, 19 of whom are from Şanlıurfa in the southeastern region of Turkiye. Overall, the clinical features of the patient cohort were consistent with those mentioned in the literature, except for one exhibited an atrophoderma vermiculatum‐like lesion, which is atypical for LP. The clinical exome sequencing analysis revealed three different homozygous variants in the ECM1 gene (NM_004425). While c.1246C>T p.(Arg416*) on Exon 8 and c.806G>A p.(Cys269Tyr) on Exon 7 were detected in 1 patient each, an intragenic deletion of 1163 base‐pairs including Exons 9 and 10 (c.1304 + 33_*300del) was identified in 18 patients from 7 unrelated families. The haplotype analysis of the deletion variant indicated a founder effect in the families from the Şanlıurfa province of Turkiye. Based on all this information, copy number variation analysis is recommended for patients with LP. In addition to this rare observation, this study represents the largest examination of the molecular spectrum of LP patients in Turkiye, alongside the clinical spectrum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular Matrix ProteinsFounder EffectLipoid Proteinosis of Urbach and WiethePedigreeHumansMaleFemaleChildAdultAdolescentSequence DeletionTurkeyExonsChild, PreschoolHaplotypesExome SequencingYoung AdultHomozygoteGenetic Predisposition to DiseasePhenotype

Stichwörter der Autor:innen

ECM1FALECdeletionfounder variantlipoid proteinosis

Substanzen

Extracellular Matrix ProteinsECM1 protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, Ankara Etlik City Hospital, Ankara, Turkey.
  • Department of Medical Genetics, Sanliurfa Education and Research Hospital, Sanliurfa, Turkey.
  • Department of Dermatology, Sanliurfa Education and Research Hospital, Sanliurfa, Turkey.

ORCID-Profile: Elifcan Taşdelen, Abdullah Sezer, Isa An

Zitieren

APA

Taşdelen, E., Sezer, A., & An, I. (2024). A founder deletion in ECM1 of 1163 bp causes lipoid proteinosis in the southeast region of Turkiye. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63782

Vancouver

Taşdelen E, Sezer A, An I. A founder deletion in ECM1 of 1163 bp causes lipoid proteinosis in the southeast region of Turkiye. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63782

BibTeX
@article{Tadelen2024,
  author = {Taşdelen, Elifcan and Sezer, Abdullah and An, Isa},
  title = {A founder deletion in ECM1 of 1163 bp causes lipoid proteinosis in the southeast region of Turkiye},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63782}
}
Kostenlos starten →